article thumbnail

Time for change: non-human primates in drug research

Drug Target Review

The FDA’s new roadmap In April 2025, the FDA announced a major regulatory shift with its plan to phase out the requirement for animal testing in the development of monoclonal antibodies and other drugs, when scientifically appropriate. NIH Office of Laboratory Animal Welfare – Training Guidelines. Bailey J, et al.

article thumbnail

Levers for Biological Progress

Codon

This essay focuses on how we might do both, specifically for the cell. Though my focus in this essay is narrow — I don’t discuss bottlenecks in clinical trials, human disease, or animal testing — I hope others will take on these challenges in similar essays. Subscribe to Asimov Press. Even the humble E.

DNA 133
article thumbnail

Advanced 3D cell-based technologies

Drug Target Review

puts an end to the previous mandate that all drugs need to be tested on animals prior to human clinical trials. Prior to this European Union Parliament, in 2021, voted for animal testing phase out. From 3D cell culture to organs-on-chips. Trends in Cell Biology. The US FDA Modernisation Act 2.0.,